Radioligand Therapy with [ 177 Lu]Lu-DOTA-TATE or [ 177 Lu]Lu-DOTA-TATE and [ 90 Y]Y-DOTA-TATE in Patients with Neuroendocrine Neoplasms of Unknown Locations, or Locations Other Than the Midgut and Pancreas as Primaries in a G1, G2 and G3 Grade. - Durma, Adam Daniel; Saracyn, Marek; Kołodziej, Maciej; Jóźwik-Plebanek, Katarzyna; Dmochowska, Beata; Mróz, Adrianna; Żmudzki, Wawrzyniec; Kamiński, Grzegorz (Pharmaceuticals (14248247), 2023)